Because melorheostosis is one of few osteosclerotic bone-forming diseases, study of the MEK1-ERK1/2 pathway may lead to insights relevant to diseases where bone formation is impaired, such as delayed fracture healing and osteoporosis. This evidence concerns the gene MAP2K1 and melorheostosis.